In the news – Comment: The mpox outbreak and its impact on travellers

mpox outbreak affect on travellers

Farhan Rafi, travel intelligence analyst at Riskline, reveals how travel companies can reassure and advise customers throughout the crisis 

The recent mpox outbreak in the Democratic Republic of Congo and the Central African Republic has raised some concerns for the travel industry and for travel companies.

The outbreak intensified in 2024, driven by the more highly transmissible Clade I strain. According to the World Health Organisation, over 120 countries reported the virus between January 2022 and August 2024, with more than 100,000 laboratory-confirmed cases. Often known as monkeypox, mpox is an infectious disease that can cause a painful rash, enlarged lymph nodes, fever, headache, muscle ache, back pain, and low energy.

Many countries with robust healthcare infrastructure, such as Japan and the United States, have controlled the situation. However, the situation is different in countries with strained and fragile healthcare systems, such as the Democratic Republic of Congo (DRC).

The mpox outbreak has had a limited effect on travel, with most destinations adopting precautionary measures rather than imposing significant restrictions. Since cross-border travellers are often the cause of new infections in neighbouring countries, surveillance measures have been implemented in over 60 destinations. The measures include filling out a health declaration, thermal screening, observation, random testing and contact tracing.

Why travel companies need to reassure and advise customers

As the mpox situation evolves, it is crucial for travel companies to actively communicate with their customers about any potential risks and preventive measures. Clear guidance on health and safety can help build trust, especially when travelling to regions with active outbreaks. Travel companies should advise customers on how to protect themselves, from avoiding contact with animals to ensuring they are vaccinated if necessary.  For higher-risk individuals, such as those who are pregnant or immunocompromised, it’s vital to consult a healthcare professional to confirm fitness for travel.

Travel companies can also advise customers to purchase travel insurance and review their policies, ensuring coverage includes medical evacuation options, as treatment availability may vary across destinations. Providing up-to-date information about screening processes and health checks at airports will also reassure travellers and prevent confusion.

By taking these steps, travel companies can help minimise disruptions, ensure customer safety, and maintain confidence in travel planning during the outbreak.

Read the full article in Travel Weekly.

For more information on the outbreak, check our mpox outbreak travel advisory.

 

Photo credits: Travel Weekly

Travel risk data for every step of the journey

Destination Research

Destination risk, safety & travel reports

Travel Search

Visa, health, safety & documention

TripReady

Pre-travel security & travel safety advisories

Realtime Alerts

Breaking on-site travel risk updates 24/7

Travel and Tech Data

Data to improve user satisfaction

Technology Solutions

APIs, widgets and portal

The Informer

Articles, news and product updates

Newsroom

The latest developments at Riskline

Forecast

Explore key global risks for 2024

Reports

In-depth content on relevant topics

Thank you!

You are now subscribed to the Riskline Informer. 

Read the latest article now